alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 520.82a Aminopropazine. ( a ) *Specifications.* Each tablet contains aminopropazine fumarate equivalent to 25 percent aminopropazine base.
( b ) *Sponsor.* See No. 000061 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs and cats* — ( 1 ) *Amount.* Administer orally at a dosage of 1 to 2 milligrams per pound of body weight, repeated every 12 hours as indicated.
( 2 ) *Indications for use.* For reducing excessive smooth muscle contractions, such as occur in urethral spasms associated with urolithiasis.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 28816, May 20, 2014]
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

VONNESSIA L. WILSON,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

Nos. 4D19-132, 19-134, 19-135 & 19-140

[November 7, 2019]

CORRECTED OPINION

Appeal from the Circuit Court for the Nineteenth Judicial Circuit, St. 

Lucie County; Steven J. Levin, Judge; L.T. Case No. 562016CF002641A, 

562016CF002820A, 562016CF003009A and 562017CF000278A.

Antony P. Ryan, Regional Counsel, and Paul O’ Neil, Assistant Regional 

Counsel, Office of Criminal Conflict and Civil Regional Counsel, West Palm 

Beach, for appellant.

Ashley Moody, Attorney General, Tallahassee, and Lindsay A. Warner, 

Assistant Attorney General, West Palm Beach, for appellee.

PER CURIAM.

Affirmed.

TAYLOR, MAY and DAMOORGIAN, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
§ 582.6851 Stearyl citrate. ( a ) *Product.* Stearyl citrate.
( b ) *Tolerance.* This substance is generally recognized as safe for use at a level not exceeding 0.15 percent in accordance with good manufacturing or feeding practice.
<PAGE>
                                                                  EXHIBIT 23.2


               CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

     As independent public accountants, we hereby consent to the 
incorporation by reference in the Registration Statement (Form S-3 No. 
33-62739) of United Stationers Inc. and in the related Prospectus of our 
report dated January 23, 1995 on the consolidated financial statements and 
schedule of Associated Holdings, Inc. as of December 31, 1994 and for the 
year ended December 31, 1994 and to all references to our Firm included in 
the Annual Report (Form 10-K) of United Stationers Inc. for the year ended 
December 31, 1996.

                                   /S/ Arthur Andersen LLP


Chicago, Illinois
March 25, 1997